116 related articles for article (PubMed ID: 10192501)
1. The relationship between defects in lymphocyte production of transforming growth factor-beta1 in systemic lupus erythematosus and disease activity or severity.
Ohtsuka K; Gray JD; Stimmler MM; Horwitz DA
Lupus; 1999; 8(2):90-4. PubMed ID: 10192501
[TBL] [Abstract][Full Text] [Related]
2. Decreased production of TGF-beta by lymphocytes from patients with systemic lupus erythematosus.
Ohtsuka K; Gray JD; Stimmler MM; Toro B; Horwitz DA
J Immunol; 1998 Mar; 160(5):2539-45. PubMed ID: 9498800
[TBL] [Abstract][Full Text] [Related]
3. Decreased serum levels of TGF-β1 are associated with renal damage in female patients with systemic lupus erythematosus.
Jin T; Almehed K; Carlsten H; Forsblad-d'Elia H
Lupus; 2012 Mar; 21(3):310-8. PubMed ID: 22072025
[TBL] [Abstract][Full Text] [Related]
4. Cytokine-mediated down-regulation of B cell activity in SLE: effects of interleukin-2 and transforming growth factor-beta.
Ohtsuka K; Gray JD; Quismorio FP; Lee W; Horwitz DA
Lupus; 1999; 8(2):95-102. PubMed ID: 10192502
[TBL] [Abstract][Full Text] [Related]
5. Single-nucleotide polymorphisms of transforming growth factor-beta1 gene in Taiwanese patients with systemic lupus erythematosus.
Lu LY; Cheng HH; Sung PK; Yeh JJ; Shiue YL; Chen A
J Microbiol Immunol Infect; 2004 Jun; 37(3):145-52. PubMed ID: 15221033
[TBL] [Abstract][Full Text] [Related]
6. The transforming growth factor-beta1 gene polymorphism (G915C) is not associated with systemic lupus erythematosus.
Schotte H; Willeke P; Rust S; Assmann G; Domschke W; Gaubitz M; Schlüter B
Lupus; 2003; 12(2):86-92. PubMed ID: 12630751
[TBL] [Abstract][Full Text] [Related]
7. Expression of intracellular transforming growth factor-beta1 in CD4+CD25+ cells in patients with systemic lupus erythematosus.
Lu LY; Chu JJ; Lu PJ; Sung PK; Hsu CM; Tseng JC
J Microbiol Immunol Infect; 2008 Apr; 41(2):165-73. PubMed ID: 18473105
[TBL] [Abstract][Full Text] [Related]
8. Th1/Th2/Th17/Treg cytokine imbalance in systemic lupus erythematosus (SLE) patients: Correlation with disease activity.
Talaat RM; Mohamed SF; Bassyouni IH; Raouf AA
Cytokine; 2015 Apr; 72(2):146-53. PubMed ID: 25647269
[TBL] [Abstract][Full Text] [Related]
9. Serum levels of angiogenic cytokines in systemic lupus erythematosus and their correlation with disease activity.
Robak E; Woźniacka A; Sysa-Jedrzejowska A; Stepień H; Robak T
Eur Cytokine Netw; 2001; 12(3):445-52. PubMed ID: 11566625
[TBL] [Abstract][Full Text] [Related]
10. Role of Treg cells and TGF-β1 in patients with systemic lupus erythematosus: a possible relation with lupus nephritis.
Xing Q; Su H; Cui J; Wang B
Immunol Invest; 2012; 41(1):15-27. PubMed ID: 21563925
[TBL] [Abstract][Full Text] [Related]
11. Expression of messenger RNA for transforming growth factor-beta1 and for transforming growth factor-beta receptors in peripheral blood of systemic lupus erythematosus patients treated with low doses of quinagolide.
Hrycek A; Kusmierz D; Dybała T; Swiatkowska L
Autoimmunity; 2007 Feb; 40(1):23-30. PubMed ID: 17364494
[TBL] [Abstract][Full Text] [Related]
12. Resistance to exogenous TGF-β effects in patients with systemic lupus erythematosus.
Elbeldi-Ferchiou A; Ben Ahmed M; Smiti-Khanfir M; Houman MH; Abdeladhim M; Belhadj Hmida N; Cerf-Bensussan N; Louzir H
J Clin Immunol; 2011 Aug; 31(4):574-83. PubMed ID: 21503670
[TBL] [Abstract][Full Text] [Related]
13. Transforming growth factor beta 1(TGF-beta1) down-regulates TNFalpha-induced RANTES production in rheumatoid synovial fibroblasts through NF-kappaB-mediated transcriptional repression.
Cho ML; Min SY; Chang SH; Kim KW; Heo SB; Lee SH; Park SH; Cho CS; Kim HY
Immunol Lett; 2006 Jun; 105(2):159-66. PubMed ID: 16564576
[TBL] [Abstract][Full Text] [Related]
14. Activation of transforming growth factor-beta1 and early atherosclerosis in systemic lupus erythematosus.
Jackson M; Ahmad Y; Bruce IN; Coupes B; Brenchley PE
Arthritis Res Ther; 2006; 8(3):R81. PubMed ID: 16646981
[TBL] [Abstract][Full Text] [Related]
15. Serum levels of transforming growth factor-β1 (TGF-β1) in patients with systemic lupus erythematosus and Hashimoto's thyroiditis.
Manolova I; Gerenova J; Ivanova M
Eur Cytokine Netw; 2013 Mar; 24(1):69-74. PubMed ID: 23614931
[TBL] [Abstract][Full Text] [Related]
16. Characterization of B cell growth in systemic lupus erythematosus. Effects of recombinant 12-kDa B cell growth factor, interleukin 4 and transforming growth factor-beta.
Flescher E; Fossum D; Ballester A; Maizel A; Sharma S; Talal N
Eur J Immunol; 1990 Nov; 20(11):2425-30. PubMed ID: 2253682
[TBL] [Abstract][Full Text] [Related]
17. Signs of impaired immunoregulation and enhanced effector T-cell responses in the primary antiphospholipid syndrome.
Jakiela B; Iwaniec T; Plutecka H; Celinska-Lowenhoff M; Dziedzina S; Musial J
Lupus; 2016 Apr; 25(4):389-98. PubMed ID: 26657472
[TBL] [Abstract][Full Text] [Related]
18. Single nucleotide polymorphism T869C of transforming growth factor-beta 1 gene and systemic lupus erythematosus: association with disease susceptibility and lupus nephritis.
Sayed SK; Galal SH; Herdan OM; Mahran AM
Egypt J Immunol; 2014; 21(2):9-21. PubMed ID: 25812349
[TBL] [Abstract][Full Text] [Related]
19. Elevated circulating CD4+ ICOS+ Foxp3+ T cells contribute to overproduction of IL-10 and are correlated with disease severity in patients with systemic lupus erythematosus.
Liu Y; Zhu T; Cai G; Qin Y; Wang W; Tang G; Zhao D; Shen Q
Lupus; 2011 May; 20(6):620-7. PubMed ID: 21558138
[TBL] [Abstract][Full Text] [Related]
20. Transforming growth factor beta 1 in children with systemic lupus erythematosus: a possible relation with clinical presentation of lupus nephritis.
Hammad AM; Youssef HM; El-Arman MM
Lupus; 2006; 15(9):608-12. PubMed ID: 17080918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
